NEVRO CORP. Deferred Tax Assets, Valuation Allowance
NEVRO CORP. had Deferred Tax Assets, Valuation Allowance of $226.93 million as of 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2025-03-04
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $226.93M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $206.33M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $200.98M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $201.09M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2024-12-31 | $226.93M 10-K · filed 2025-03-04 |
| 2023-12-31 | $206.33M 10-K · filed 2025-03-04 |
| 2022-12-31 | $200.98M 10-K · filed 2024-02-23 |
| 2021-12-31 | $201.09M 10-K · filed 2023-02-21 |
| 2020-12-31 | $164.28M 10-K · filed 2022-02-23 |
| 2019-12-31 | $131.81M 10-K · filed 2021-02-24 |
| 2018-12-31 | $100.75M 10-K · filed 2020-02-25 |
| 2017-12-31 | $88.12M 10-K · filed 2019-02-21 |
| 2016-12-31 | $85.73M 10-K · filed 2018-02-22 |
| 2015-12-31 | $67.03M 10-K · filed 2017-02-23 |
| 2014-12-31 | $43.67M 10-K · filed 2016-02-29 |
| 2013-12-31 | $34.27M 10-K · filed 2016-02-29 |
| 2012-12-31 | $24.31M 10-K · filed 2015-03-18 |